Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-18-020147
Filing Date
2018-04-27
Accepted
2018-04-27 16:10:53
Documents
5
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A bp09373x2_defa14a.htm DEFA14A 22977
2 bp09373x2_proxycard01.jpg GRAPHIC 115668
3 bp09373x2_proxycard02.jpg GRAPHIC 204120
4 bp09373x2_proxycard03.jpg GRAPHIC 60995
5 bp09373x2_proxycard04.jpg GRAPHIC 7818
  Complete submission text file 0001140361-18-020147.txt   551847
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33277 | Film No.: 18783957
SIC: 2834 Pharmaceutical Preparations